News

Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
Fierce Pharma20h
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...
Exclusive: Kennedy's new vaccine adviser was expert witness against Merck vaccine
One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...
STAT9d
Pharmalittle: We’re reading about Merck eyeing a biotech, a Moderna Covid vaccine trial, and more
Merck held talks over a potential $3 billion acquisition of MoonLake Immunotherapeutics, as it seeks to replenish its drug ...
Merck Receives FDA Approval for Treatment of Head, Neck Cancers
The Rahway, N.J., drug maker said Friday that its treatment, Keytruda, has been approved for adult patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express ...
Merck's potential blockbuster cholesterol pill succeeds in late-stage studies
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the ...